期刊文献+

hCAP-18/LL-37全长肽真核表达产物对树突状细胞分化成熟的影响 被引量:1

The effects of eukaryotic expression products of the whole range peptide of hCAP-18/LL-37 on differentiation and maturation of DC
下载PDF
导出
摘要 目的研究人源阳离子抗菌肽(hCAP)-18/LL-37全长肽真核表达产物对树突状细胞分化成熟的影响。方法将已构建的hCAP-18/LL-37全长肽真核表达载体pcDNA4/Myc-His-hCAP-18转染Hela细胞株,在转染后48 h收获培养上清;人外周血单个核细胞分离,体外定向诱导分化成树突状细胞(DC);将转染后收获的培养上清与体外培养的DC共同孵育,48 h收获DC,经流式细胞仪检测DC表面分子CD83、CD86、CD40及HLA-DR的表达。结果FCM结果显示:pcDNA4/Myc-His-hCAP-18转染Hela细胞培养上清与pcDNA4/Myc-His空载体转染细胞培养上清相比较,均可上调DC表面分子CD86、CD40及HLA-DR的表达。结论构建的hCAP-18/LL-37全长肽真核表达载体pcDNA4/Myc-His-hCAP-18转染Hela细胞株培养上清液均可上调DC表面分子CD86、CD40及HLA-DR的表达,促进DC的分化成熟。 Objective Objective To study The effects of eukaryotic expression products of the whole range peptide of hCAP-18/ LL-37 on differentiation and maturation of DC. Methods pcDNA4/Myc-His-hCAP-18 for the whole peptide was transfected into Hela cell line. After the cells were cultured for 48 h the supernatant was collected. We prepared human peripheral blood monouclear cells and induce them into DC in vitro. Then we add the supematant collected from the transfected cells and continued culturing the DC for 48 h. By FCM we detected the surface molecules on DC which are related with the differentiation and maturation of DC such as CD83, CD86, CIMO and HLA-DR. Results We detected the mature peptide expression in'the Hela cell transfected by pcDNA4/Myc-His- hCAP-18. FCM indicated that CD86 ,CD40及. HLA-DR on the surface of DC which were stimulated by the pcDNA4/Myc-His-hCAP- 18 supernatant are more expressed than them on the surface of DC which were stimulated by the supernatant produced by pcDNA4/ Myc-His naked vector. Conclusion The whole range peptide of hCAP-18/LL-37 that we constructed and expressed can increase the expression of the DC surface molecules which are related with the differentiation and maturation of DC and promote differentiation and maturation of DC.
出处 《中国实验诊断学》 北大核心 2010年第3期346-348,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科学技术厅发展计划项目(200705357)
关键词 抗菌肽 hCAP-18/LL-37 真核表达 树突状细胞 antimicrobial peptide hCAP- 18/LL-37 eukaryotic expression dendritic cells
  • 相关文献

参考文献6

  • 1Barlow P G, Y Li, Wilkinson T S, et al. The hnman cationic host defense peptide LL-37 mediates contrasting effects on apoptotie pathways in different primary cells of the innate immune system[ J]. J Leukoc Biol, 2006,80 (3) :509.
  • 2Niyonsaba F A, Someya M, Hirata, et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells[J]. Eur J Immunol, 2001,31 (4) :1066.
  • 3Chen X F, Niyonsaba H Ushio, et al. Human cathelicidin LL-37 increases vascular pemleability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells[J]. J Dermatol Sci, 2006, 43(1) :63.
  • 4Zuyderduyn S, Ninaber D K, Hiemstra P S, et al. The antimicmbial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells [J]. J Allergy Clin Immunol, 2006, 117(6) : 1328.
  • 5Bowdish D M, Davidson D J, Hancock R E. Immunomodulatory properties of defensins and cathelicidins [ J ]. Curt Top Microbiol Immunol, 2006, 306:27.
  • 6Bandholtz L, Ekman G J, Vilhelmsson M, et al. Antimicrobial peptide LL- 37 internalized by immature human dendritic cells alters their phenotype [J]. Seand J Immunol,2006,63(6) :410.

同被引文献11

  • 1Barlow PG, Li Y, Wilkinson TS, et al. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system [J]. J Leukoc Biol, 2006, 80 (3): 509-520.
  • 2Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticum [J]. J Allergy Clin Immunol, 2006, 117 (4) : 836-841.
  • 3Heilbom JD, Nilsson MF, Kratz G, et al. The eathelieidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium [J]. J Invest Dermatol, 2003, 120 (3): 379-389.
  • 4Akashi-Takamura S, Miyake K. Toll-like receptors(TLRs) and immune disorders [J]. J Infect Chemother, 2006, 12 (5): 233-240.
  • 5Koczulla R, Von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J]. J Clin Invest, 2003, 111 (11): 1665-1672.
  • 6Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a laetoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties [J]. Cell Mol Life Sci, 2005, 62 (22): 2588-2598.
  • 7Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases [J]. Inflammopharmacology, 2007, 15 (6): 252-259.
  • 8Rivas-Santiago B, Hemandez-Pando R, Carranza C, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells [J]. Infect Immun, 2008, 76 (3): 935-941.
  • 9Elssner A, Duncan M, Gavrilin M, et al. A novel P2X7 receptor activator, the human eathelicidin-derived peptide LL37, induces IL-1 beta processing and release [J]. J Immunol, 2004, 172 ( 8 ) : 4987-4994.
  • 10Yu J, Mookherjee N, Wee K, et al. Host defense peptide LL- 37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways [J]. J Immunol, 2007, 179 ( 11 ) : 7684-7691.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部